Table:
begin	end	state
1	18	cytoplasmic
19	38	transmembrane
39	43	non-cytoplasmic
44	63	transmembrane
64	90	cytoplasmic
91	119	transmembrane
120	124	non-cytoplasmic
125	143	transmembrane
144	154	cytoplasmic
155	177	transmembrane
178	199	non-cytoplasmic
200	223	transmembrane
224	242	cytoplasmic
243	263	transmembrane
264	276	non-cytoplasmic
277	302	transmembrane
303	332	cytoplasmic
333	354	transmembrane
355	359	non-cytoplasmic
360	382	transmembrane
383	402	cytoplasmic
403	425	transmembrane
426	430	non-cytoplasmic
431	449	transmembrane
450	469	cytoplasmic

Input:
>GFF344
MQQQEKGLKRGLSARHIRFMALGSAIGTGLFYGSASAIQMAGPAVLLAYLIGGAAVFMVM
RALGEMAVHNPVAGSFGQYASTYLGPMAGFILGWTYAFEMIIVCLADVTAFGIYMGFWFP
DVARWVWVLGIVLLIGGLNLCNVKVFGEMEFWLSLLKVGAIVAMILGGFGIMLFGIHSAG
ETQASGLSNLWAHGGFMPNGIGGLIASFAVVMFAFGGIEIIGITAGEAKDPQRVIPKAIN
AVPLRILLFYVLTLFVLMAIYPWPQIGSQGSPFVQIFSNLGIGSAATILNIVVISAAVSA
INSDIFGAGRMMYGLAQQGQAPKGFAQLSKQGVPWMTVVVMGAALLGGVVLNYLIPENVF
LVIASIATFATVWVWLMILFTQVAMRRSMTKEQVAELKFPVPFWPYAPAAAIVFMLFVFG
VLGYFPDTQAALLVGAVWIVLLVVAYLLWVKPSAGQAAKVHYDAALSHR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server